Pharmacogenetic Syndrome of Dihydropyrimidine Dehydrogenase Deficiency

By  

Current Pharmacogenomics, Vol. 5, Iss. 1, 2007-03 ,pp. : 31-38

Bentham Science Publishers

Access to resources Recommend Favorite

The Effect of Dihydropyrimidine Dehydrogenase Deficiency on Outcomes with Fluorouracil

By Gardiner S.J.  

Adverse Drug Reactions & Toxicological Reviews (now known as Toxicological Reviews), Vol. 21, Iss. 1-2, 2002-01 ,pp. : 1-16

Adis International

Access to resources Recommend Favorite

Implications of dihydropyrimidine dehydrogenase on 5-fluorouracil pharmacogenetics and pharmacogenomics

By Mattison Lori K   Soong Richie   Diasio Robert B  

Pharmacogenomics, Vol. 3, Iss. 4, 2002-07 ,pp. : 485-492

Future Medicine

Access to resources Recommend Favorite

Capecitabine: Severe toxicity and death in a patient with dihydropyrimidine dehydrogenase deficiency: case report

By  

Reactions Weekly, Vol. 1, Iss. 1174, 2007-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Diagnostic analysis, clinical importance and molecular basis of dihydropyrimidine dehydrogenase deficiency

By Gonzalez F.J.   Fernandez-Salguero P.  

Trends in Pharmacological Sciences, Vol. 16, Iss. 10, 1995-10 ,pp. : 325-327

Elsevier

Access to resources Recommend Favorite